Pharmaceuticals Market Research Reports & Industry Analysis

... 249-page report from VPGMarketResearch provides a comprehensive analysis of the US therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market ... products, such as specimen preparation devices, controls, calibrators and others. US Therapeutic Drug Monitoring (TDM) Market 2015: Hospitals, Commercial Labs, Physician Offices is a unique market ...

... imperative to engage? Expanded Access Programs: Opportunities and Challenges for Pharma is a detailed report for industry management who must assess, approve or manage expanded access requests and ... and “real-world” research benefits of engaging in expanded access programmes Assess whether running your own expanded access programmes or engaging a service company is the route ...

... United States Off–Label Drugs market. This 67 page report with 16 Figures and 1 Table studies 6 Off–Label Drugs Segment. The 6 Off–Label Drugs Segment Covered in the Report are as Follows: 1. Cancer Off–Label Drugs 2. Central Nervous System (CNS) Off–Label Drugs 3. Anti–Ashmatics Off–Label Drugs 4. Anti ...

... Pneumococcal vaccines (PCV) and Varicella vaccines are the leading market share holder in Canada and together they contribute more than 50% of the total Pediatric vaccines market. Polio, Measles, Mumps & Rubella (MMR), Diphtheria, Tetanus & Pertussis (DTaP ...

... Global Interferon Market & Pipeline Analysis 2015” Report Highlights: Introduction & Classification of Interferons Interferon Clinical Pipeline Country, Indication & Phase Interferon Clinical Pipeline: 79 Drugs Majority Interferon Drugs in Preclinical Phase: 29 Drugs Marketed Interferon Drugs: 37 Drugs ...

... Global Peptide Hormone Market Overview Peptide Hormones Clinical Pipeline by Company, Indication & Phase Marketed Peptide Hormones by Company & Indication Peptide Hormones Clinical Pipeline: 47 Drugs Majority Peptide Hormone in Phase-II Trials: 15 Drugs Marketed Peptide Hormones: 24 Drugs Global Peptide ...

... Global Diabetes Drug Market Overview Global Diabetic Drug Clinical Pipeline by Company & Phase Global Diabetic Drug Clinical Pipeline: 817 Drugs Majority in Preclinical Phase: 205 Drugs Type 2 Diabetes Mellitus Drugs in Pipeline: 380 Drugs Type 1 Diabetes Mellitus Drugs in Pipeline: 79 Drugs Diabetic ...

... Oncogene Inhibitors Pipeline: 185 Drugs Majority Oncogene Inhibitors in Preclinical Phase: 105 Drugs Proto Oncogene Protein c met Inhibitors Pipeline: 42 Drugs Proto Oncogene Protein c-akt Inhibitors: 39 Drugs Marketed Oncogene Inhibitors: 22 Drugs Marketed Proto-Oncogene Protein c-bcl-2 Inhibitors: 8 Drugs ...

... Tyrosine Kinase Therapeutics Global Tyrosine Kinase Inhibitors Pipeline by Company, Indication & Phase Global Tyrosine Kinase Inhibitors Pipeline: 557 Drugs Majority Drugs in Preclinical Phase: 239 Drugs Marketed Tyrosine Kinase Inhibitors: 58 Drugs Marketed Tyrosine Kinase Inhibitors ...

... Cancer Targeted Therapy Market & Clinical Insight” Report Highlight: Introduction & Categorization of Cancer Targeted Therapies Mechanism of Cancer Targeted Tyrosine Kinase, Vaccines, Oncogenes Inhibitors, Monoclonal Antibodies Cancer Targeted Therapy ...

... Cancer Growth Inhibitors Cancer Growth Inhibitors Clinical Pipeline by Company, Indication & Phase Cancer Growth Inhibitors Clinical Pipeline: 629 Drugs Markets Cancer Growth Inhibitors: 48 Drugs Tyrosine Kinase Dominates Cancer Growth Inhibitors Pipeline: 394 Drugs HDAC Inhibitors Clinical Pipeline: 65 Drugs ...

... registration for meningococcal polysaccharide vaccine (Group A/C/Y/W 135) and other vaccines in Nigeria, Chile, Peru, Thailand, and India. China Human Vaccine Industry Report, 2015-2018 highlights the following: Operating environment, overall situation, sales channel, etc. of China human vaccine industry; Supply & demand ...

... , namely, adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software. The global pharmacovigilance and drug safety software market is segmented into two segments ... : Comprehensive information on pharmacovigilance and drug safety software offered by the top 10 players in the pharmacovigilance and drug safety software market. The report analyzes the pharmacovigilance and drug safety software market on the basis ...

... “Pharmaceutical Contract Packaging Plant Project Report: Industry Trends, Manufacturing Process, Machinery, Raw Materials, Cost and Revenue” provides a techno-commercial roadmap for setting up a Pharmaceutical Contract Packaging plant. The ... for setting up a Pharmaceutical Contract Packaging plant? What are the utility requirements for setting up a Pharmaceutical Contract Packaging plant? What are the manpower requirements for setting up a Pharmaceutical Contract Packaging plant? What are ...

... challenges lie ahead for the specialty pharmaceutical market in the US, including the ... specialty pharmaceuticals sales of the overall US pharmaceuticals sales continues to rise. The report, “The US Specialty Pharmaceuticals Market: 2015 Edition” analyzes the growth and development of specialty pharmaceutical ...

... 2013 and 2014: Supply situation has been playing a dominant role in the performance of China's vitamin industry since 2013, ... trend of China's vitamin industry. What to report: An overview of China's vitamin production, 2011-2013; Price changes of China's vitamins, 2011-Sept. 2014; Dynamics of leading vitamin ...

... -2019 Shares of different product segments of the overall pharmaceutical, laboratory and hygienic glassware market, 2008, 2014 and 2019 Market Potential ... , current market situation, trends, and future outlook of the pharmaceutical, laboratory and hygienic glassware market in the world to 2019 Track industry ...

... of NCE/mAb development by Indian companies is a sign of Indian Generics moving up in the chain. Biopharma/ biotech companies in India, S. Korea, China may have significant advantages of low-cost manufacturing ...

... Lung Cancer Vaccine Global Lung Cancer Vaccine Market Analysis Global Lung Cancer Vaccine Pipeline by Company & Phase Global Lung Cancer Vaccine Pipeline: 29 Vaccines Majority Lung Cancer Vaccines in Phase-II: 8 Vaccines Marketed Lung Cancer Vaccines: 3 ( BV NSCLC 001, Mycidac-C & Vaxira) Personalized Cancer ...

... Skin Cancer Vaccine Global Skin Cancer Vaccine Market Analysis Global Skin Cancer Vaccine Pipeline by Company & Phase Global Skin Cancer Vaccine Pipeline: 47 Vaccines Majority Skin Cancer Vaccines in Phase-I: 12 Vaccines Marketed Skin Cancer Vaccines ...

... per-capita income, and strong research & development investments, the pharmaceutical market in the US has witnessed an upward surge over the past few ... are holding back growth in the Generics industry. According to RNCOS “US Generic Drug Market Outlook 2018”, the US Generics market, which was US$ 43.5 Billion ...

... of report: In this report, CCM has analyzed price of feed-grade vitamins in 2014. What to report: In this report, China's feed-grade vitamin prices in 2014 have been analyzed exhaustively from ...

... pricing system adopted in Japan from April -2014 (Annexure 1) is a game changer initiative. It pains most of the companies - whether generic ... Outlook-15, we look deeper into these trends to anticipate likely near term changes of Japanese pharma ... Edoxaban, Lenvatinib, Entyvio, Brintellix, and Ixazomib are the few ...

... diabetes (SGLT-2, GLP-1 agonists), Multiple Sclerosis, HCV, melanoma and breast cancer from major ... anti-PD1, anti-PCSK9 and CDK inhibitors have also got exclusive attention by large cap Pharma ... business among major pharma including Vaccines, OTC and animal health to improve margins. Global Pharma continues to ...

... the healthcare needs of the country. Sri Lanka’s total expenditure on health has increased by ~11%, CAGR (2005-2010), and this has been driven by both private- (+12%) and government ...

... clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings of companies developing and marketing ... . This report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios ...

... , biochips, genosensors, microarrays, labs-on-the-chip, and other.The report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative ...

... is already available on the market, e.g., DNA extractors, DNA synthesizers, thermal cyclers, robotic work-stations, and automated DNA probe analysis systems. The report reviews current instrumentation technologies, and compares features of leading molecular diagnostics analyzers marketed by Abbott, Beckman ...

... for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others."Drugs of Abuse Testing Market: US, Europe, Japan" is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging ...

... , as well as test volume and sales forecasts by country. The report also presents strategic profiles of current and emerging suppliers of nucleic acid testing products in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and ...

This report provides: Estimates of facilities performing DNA sequencing and molecular diagnostic testing in France, Germany, Italy, Japan, Spain, UK and USA. Five-year test volume and sales forecasts by country.

... a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others."Therapeutic Dry Monitoring: US, Europe, Japan" is a unique worldwide market and technology assessment designed to help current suppliers and potential market entrants ...

... Competitor Analysis: Alpha Synuclein and LRRK2 Inhibitors - Novel Drug Candidates for Parkinson's Disease The Competitive Intelligence report about Alpha ... on inhibitors of the molecular targets alpha-synuclein and LRRK2 including small molecules, antibodies, vaccines and RNAi. Competitor projects are listed ...

... new opportunities or geography expansion in the functional food, beverage, and supplement (FBS) market. Nutraceutical is divided into three segments – dietary supplements, functional foods and functional beverages. Globally, Nutraceuticals ...

Traditionally Innovation and drug discovery had taken a back seat in the Indian pharma industry with a few blips here and there. ... 2-3 years thereby rewarding their investors. . In this Outlook we have initiated coverage on Connexios, Bugworks, Cellworks, Tergene and hope that soon we will be able to expand ...

... CCM has analyzed hot spots in China's vitamin industry in 2014. What to report: In this report, hot spots in China's vitamin industry in 2014 ... have been analyzed exhaustively from the following aspects: Background; Company dynamics; Market prices change of vitamins ...

... cases and 35,600 cases respectively. Liver disease drug market competition of our country is really fierce. China’s liver disease drug market can be divided ... data issued by China Competition Information shows that, the scale of China liver disease drug market is close to RMB 43 billion in 2013. China has become the ...

This report analyzes the worldwide markets for Biopharmaceuticals in US$ Million by the following Segments: Recombinant Protein, Monoclonal Antibodies (mAbs), ... 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

This report analyzes the worldwide markets for H1N1 Vaccines in US$ Million. The report provides separate comprehensive analytics for the US, ... 2020. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

... most likely that the EU Regulation for Orphan medicinal products would have a significant impact in the coming years. “Europe Orphan Drug Market & Clinical ... Orphan Drug Status Comprehensive Insight on Orphan Drug Clinical Pipeline Europe Orphan Drug Clinical Pipeline: 326 Drugs Majority Orphan Designated ...

... Global Peptide Vaccine Market & Pipeline Insight” Report Highlights: Introduction & Mechanism of Peptide Vaccine Peptide Vaccine Market Overview Peptide Vaccine Market Dynamics (Drivers, Challenges & Future Outlook) Peptide Vaccine Pipeline by Phase, Indication, Company & Country Peptide Vaccine Pipeline ...

... The higher sales will depend upon efficacy of newly developed intramuscular drug and marketing strategy to drive its sales. They are used ... supposed to be cost effective along with pharmacologically efficient and minimized side effects. “Intramuscular Drug Delivery Market & Pipeline Insight” Report Findings: ...

... life threatening effects. Also, every year large number of protein based drugs are introduced in market for the treatment of various ailments. ... innovative products with higher therapeutic capabilities will enter in market in coming years. “Subcutaneous Drug Delivery Market & Pipeline Insight” Report Findings ...

... global EPO drugs market would reach $11.9 billion by 2020, registering CAGR of 9.7% during 2014-2020. Amongst all synthetic erythropoietin products, Epoetin alfa ... Ltd., Ranbaxy Laboratories Ltd., and Celltrion, Inc. Global Erythropoietin Drugs Market sidebar KEY BENEFITS An in-depth analysis of current research ...

... by the introduction of cheaper products made available by local manufacturers. Some key market players of antidiabetics include Sanofi Aventis, Takeda Pharmaceuticals ... Research has segmented the global antidiabetics market on the basis of product and region: Global Insulin Product Outlook (Revenue, USD Million ...

This report analyzes the worldwide markets for Calcium Carbonate in Metric Tons by the following Product Segments: Ground Calcium Carbonate, and Precipitated Calcium ... 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and ...

This report analyzes the worldwide markets for Vitamins in US$ ThousandS by the following Product types - Vitamin A, Vitamin B Complex, Vitamin C, Vitamin D, Vitamin E, and Vitamin K. Specific End-Use Segments also ... 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

... Non Small Cell Lung Cancer Market & Pipeline Insight” Report Highlights: NSCLC Therapy Market Overview Mechanism of NSCLC Therapeutics NSCLC Therapy Market Dynamics: Drivers, Challenges & Future Prospects) NSCLC Drug Pipeline ...

... Report The report titled “Global Combined Hormonal Contraceptive (CHC) Market: Trends and Opportunities (2014-2019)” provides an in-depth analysis of the global CHC market with detailed analysis ... Inc. Actavis Plc. Bayer Healthcare Teva Pharmaceuticals Executive Summary Combined Hormonal Contraceptives (CHC) is widely being used as an effective and reversible birth control method ...

FirstWord’s Trends and Innovations in Drug Pricing report dissects international trends and examines how long-standing dynamics in competitive pricing and ... research and expert interviews, Trends and Innovations in Drug Pricing is an open window to the future of drug pricing. Worldwide, the trend towards payers determining price has ...